$12.45
0.09[0.73%]
At close: Apr 26
$12.45
0[0.00%]
After Hours: 4:20PM EDT
Entrada Therapeutics
(NASDAQ:TRDA)Entrada Therapeutics Stock (NASDAQ:TRDA), Insider Trading Activity
Entrada Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
875.154K
Insider Percentage Owned
2.60%
Institutional Shares Held
6.863M
Institutional Percentage Held
20.4%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2024 | PETER KIM | DIRECTOR | 2.6K | $13.57 | $35.29K | BUY | 4.31% | 62.936K | Apr 08 | View |
| Apr 01, 2024 | PETER KIM | DIRECTOR | 1.512K | $13.75 | $20.79K | BUY | 2.57% | 60.336K | Mar 28 | View |
| Mar 26, 2024 | PETER KIM | DIRECTOR | 9.048K | $13.58 | $122.88K | BUY | 18.18% | 58.824K | Mar 22 - Mar 26 | View |
| Mar 21, 2024 | PETER KIM | DIRECTOR | 2.732K | $12.81 | $35.00K | BUY | 5.81% | 49.776K | Mar 19 - Mar 21 | View |
| Mar 08, 2024 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | -4.086K | $12.31 | -$50.29K | SELL | -5.22% | 74.17K | Mar 06 | View |
| Mar 08, 2024 | Nathan Dowden | PRESIDENT & COO | -1.826K | $12.32 | -$22.50K | SELL | -1.31% | 137.204K | Mar 06 | View |
| Feb 20, 2024 | Dipal Doshi | CEO | -1K | $15.00 | -$15.00K | SELL | -0.41% | 243.279K | Feb 15 | View |
| Jan 18, 2024 | Dipal Doshi | CEO | -1K | $15.99 | -$15.99K | SELL | -0.41% | 244.279K | Jan 16 | View |
| Dec 26, 2023 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0 | $8.84 | -$168.60K | SELL-OPTIONS | 0.00% | 49.571K | Dec 21 - Dec 26 | View |
| Dec 22, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1K | $15.00 | -$15.00K | SELL | -0.41% | 245.279K | Dec 20 | View |
| Nov 13, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1K | $16.23 | -$16.23K | SELL | -0.40% | 246.279K | Nov 13 | View |
| Oct 19, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1K | $15.00 | -$15.00K | SELL | -0.40% | 247.279K | Oct 17 | View |
| Sep 15, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1K | $15.00 | -$15.00K | SELL | -0.40% | 248.279K | Sep 13 | View |
| Sep 06, 2023 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 12.824K | $13.78 | -$18.97K | GRANT | 34.90% | 49.571K | Sep 01 - Sep 06 | View |
| Sep 06, 2023 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 12.907K | $13.78 | -$17.82K | GRANT | 47.57% | 40.037K | Sep 01 - Sep 06 | View |
| Sep 06, 2023 | Nathan Dowden | CHIEF OPERATING OFFICER | 12.792K | $13.77 | -$19.39K | GRANT | 36.16% | 48.168K | Sep 01 - Sep 06 | View |
| Aug 16, 2023 | Dipal Doshi | PRESIDENT AND CEO | -1K | $15.67 | -$15.67K | SELL | -0.49% | 201.069K | Aug 14 | View |
| Aug 04, 2023 | NERISSA KREHER | CHIEF MEDICAL OFFICER | 0 | $8.43 | -$338.13K | SELL-OPTIONS | 0.00% | 27.13K | Aug 02 - Aug 04 | View |
| Jul 12, 2023 | JAMES KORY WENTWORTH | CHIEF FINANCIAL OFFICER | 0 | $10.04 | -$158.86K | SELL-OPTIONS | 0.00% | 36.747K | Jul 10 - Jul 11 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.